Cormorant Asset Management LP 13D and 13G filings for Cabaletta Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 3:01 pm Sale |
2023-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Cormorant Asset Management LP | 0 0.000% |
-1,971,739![]() (Position Closed) |
Filing |
2023-02-14 3:09 pm Sale |
2022-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Cormorant Asset Management LP | 1,971,739 6.770% |
-28,261![]() (-1.41%) |
Filing |
2022-10-31 4:01 pm Purchase |
2022-10-20 | 13G | Cabaletta Bio, Inc. CABA |
Cormorant Asset Management LP | 2,000,000 7.810% |
845,576![]() (+73.25%) |
Filing |
2022-02-14 3:12 pm Sale |
2021-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Cormorant Asset Management LP | 1,154,424 4.070% |
-750,000![]() (-39.38%) |
Filing |
2021-02-16 3:14 pm Sale |
2020-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Cormorant Asset Management LP | 1,904,424 7.920% |
-214,709![]() (-10.13%) |
Filing |